Jubilant Flame International, Ltd. Reports Financial Results for the Six-Month Period Ended August 31, 2024

Press release · 10/10 14:30
Jubilant Flame International, Ltd. Reports Financial Results for the Six-Month Period Ended August 31, 2024

Jubilant Flame International, Ltd. Reports Financial Results for the Six-Month Period Ended August 31, 2024

Jubilant Flame International Ltd, a Nevada-based company, has filed its Form 10-Q for the quarterly period ended August 31, 2024. The company reported total assets of $X, total liabilities of $Y, and a stockholders’ deficit of $Z. Revenue for the six-month period ended August 31, 2024 was $X, with net income of $Y. The company’s cash and cash equivalents decreased by $X to $Y, and its accounts payable and accrued expenses increased by $X to $Y. The company’s management’s discussion and analysis highlights the company’s financial performance, including its revenue growth and profitability. The company also provides a discussion of its market risk, controls and procedures, and risk factors.

Overview of Jubilant Flame International, Ltd.

Jubilant Flame International, Ltd. is a company that has undergone several name and business changes since its inception in 2009. Initially, it provided web development and marketing services, but in 2012, it disposed of its subsidiary and shifted its focus to the medical sector. In 2015, the company changed its name to Jubilant Flame International, Ltd.

From 2018 to 2020, the company marketed and sold cosmetic products imported from Asia in the United States. However, it ceased this business line in early 2020. Since the third quarter of the fiscal year ended February 29, 2020, the company has been providing technical support services for the development of new nutrition food products to sell to customers in the USA, but this new business line has not generated significant revenue.

Financial Performance

Revenue:

  • The company reported no sales revenue in the three and six months ended August 31, 2024, the same as the corresponding periods in 2023.

Operating Expenses:

  • For the three months ended August 31, 2024, the company’s operating expenses decreased by $2,874 compared to the same period in 2023, primarily due to a decrease in professional fees.
  • For the six months ended August 31, 2024, the company’s operating expenses decreased by $4,547 compared to the same period in 2023, mainly due to a decrease in professional fees.

Net Loss:

  • The company reported a net loss of $10,069 for the three months ended August 31, 2024, compared to a net loss of $12,943 for the same period in 2023.
  • For the six months ended August 31, 2024, the company reported a net loss of $32,240, compared to a net loss of $36,787 for the same period in 2023.

Liquidity and Capital Resources:

  • As of August 31, 2024, the company had a working capital deficit of $1,329,153, with current assets of $5,035 and current liabilities of $1,334,188.
  • The company has an accumulated deficit of $3,818,184 as of August 31, 2024, which raises substantial doubt about its ability to continue as a going concern.
  • The company will need to obtain additional financing, either through the sale of equity securities, debt offerings, or borrowings, to fund its operations and execute its business plan in the nutrition product technology support sector.

Strengths and Weaknesses

Strengths:

  • The company has shifted its focus to the nutrition product technology support sector, which may provide new growth opportunities.
  • The company has been able to reduce its operating expenses, particularly in the area of professional fees.

Weaknesses:

  • The company has a significant working capital deficit and accumulated deficit, which raises concerns about its ability to continue as a going concern.
  • The company has not been able to generate significant revenue from its current business activities.
  • The company is heavily reliant on external financing to fund its operations, which may be challenging to obtain.

Outlook

The company’s future outlook is uncertain due to its significant financial challenges. The company will need to secure additional financing, either through equity, debt, or borrowings, to fund its operations and execute its business plan in the nutrition product technology support sector. If the company is unable to obtain the necessary financing, it may not be able to continue as a going concern. The success of the company’s new business line in the nutrition product technology support sector will be crucial in determining its long-term viability.